James O. Wilson

Array ( [id] => 4333478 [patent_doc_number] => 06313286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-06 [patent_title] => 'Nucleoside analogues' [patent_app_type] => 1 [patent_app_number] => 9/117494 [patent_app_country] => US [patent_app_date] => 1999-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16520 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 195 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/313/06313286.pdf [firstpage_image] =>[orig_patent_app_number] => 117494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435984 [patent_doc_number] => 06355627 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Branched cyclodextrin clathrate compound of hinokitiols and composition containing the same' [patent_app_type] => B1 [patent_app_number] => 09/244106 [patent_app_country] => US [patent_app_date] => 1999-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5973 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355627.pdf [firstpage_image] =>[orig_patent_app_number] => 09244106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006906 [patent_doc_number] => 06005098 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => '5\'deoxycytidine derivatives' [patent_app_type] => 1 [patent_app_number] => 9/234200 [patent_app_country] => US [patent_app_date] => 1999-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8389 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/005/06005098.pdf [firstpage_image] =>[orig_patent_app_number] => 234200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4217185 [patent_doc_number] => 06087345 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-11 [patent_title] => 'Material inhibiting lipid peroxide-increase' [patent_app_type] => 1 [patent_app_number] => 9/234122 [patent_app_country] => US [patent_app_date] => 1999-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1179 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/087/06087345.pdf [firstpage_image] =>[orig_patent_app_number] => 234122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4373884 [patent_doc_number] => 06288256 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Fluoroalkyl-functional organopolysiloxane-containing compositions based on water, a process for their preparation and their use' [patent_app_type] => 1 [patent_app_number] => 9/229124 [patent_app_country] => US [patent_app_date] => 1999-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6831 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 382 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288256.pdf [firstpage_image] =>[orig_patent_app_number] => 229124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4423428 [patent_doc_number] => 06225462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Conjugated polysaccharide fabric detergent and conditioning products' [patent_app_type] => 1 [patent_app_number] => 9/229043 [patent_app_country] => US [patent_app_date] => 1999-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6305 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225462.pdf [firstpage_image] =>[orig_patent_app_number] => 229043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4239681 [patent_doc_number] => 06143883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-07 [patent_title] => 'Water-soluble low molecular weight beta-glucans for modulating immunological responses in mammalian system' [patent_app_type] => 1 [patent_app_number] => 9/224145 [patent_app_country] => US [patent_app_date] => 1998-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3481 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/143/06143883.pdf [firstpage_image] =>[orig_patent_app_number] => 224145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4181450 [patent_doc_number] => 06037466 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-14 [patent_title] => 'Method for preparing hydrophobic starch derivatives' [patent_app_type] => 1 [patent_app_number] => 9/224458 [patent_app_country] => US [patent_app_date] => 1998-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2864 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/037/06037466.pdf [firstpage_image] =>[orig_patent_app_number] => 224458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4251888 [patent_doc_number] => 06207649 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Nucleoside analogs and uses in treating disease' [patent_app_type] => 1 [patent_app_number] => 9/220307 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22559 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207649.pdf [firstpage_image] =>[orig_patent_app_number] => 220307 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4108992 [patent_doc_number] => 06057301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Hyperhydrated citicoline, process and use' [patent_app_type] => 1 [patent_app_number] => 9/219595 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7237 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057301.pdf [firstpage_image] =>[orig_patent_app_number] => 219595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314211 [patent_doc_number] => 06242428 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Nucleoside analogs and uses in treating Plasmodium falciparum infection' [patent_app_type] => 1 [patent_app_number] => 9/219947 [patent_app_country] => US [patent_app_date] => 1998-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 24346 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242428.pdf [firstpage_image] =>[orig_patent_app_number] => 219947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500784 [patent_doc_number] => 06486136 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Combinations comprising VX478, zidovudine and/or 1592U89 for use in the treatment of HIV' [patent_app_type] => B1 [patent_app_number] => 09/202674 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5357 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486136.pdf [firstpage_image] =>[orig_patent_app_number] => 09202674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1392124 [patent_doc_number] => 06544961 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-08 [patent_title] => 'Combinations comprising VX478, zidovudine, FTC and/or 3TC for use in the treatments of HIV' [patent_app_type] => B1 [patent_app_number] => 09/202660 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5387 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/544/06544961.pdf [firstpage_image] =>[orig_patent_app_number] => 09202660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4240524 [patent_doc_number] => 06166198 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Methods for oligonucleotide synthesis' [patent_app_type] => 1 [patent_app_number] => 9/213991 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8701 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166198.pdf [firstpage_image] =>[orig_patent_app_number] => 213991 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4367982 [patent_doc_number] => 06274565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Inhibitor of activation of .beta.-glucan recognition protein' [patent_app_type] => 1 [patent_app_number] => 9/211043 [patent_app_country] => US [patent_app_date] => 1998-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6770 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274565.pdf [firstpage_image] =>[orig_patent_app_number] => 211043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550897 [patent_doc_number] => 06399589 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Biologically active phosphotriester-type compounds' [patent_app_type] => B1 [patent_app_number] => 09/209080 [patent_app_country] => US [patent_app_date] => 1998-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10383 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399589.pdf [firstpage_image] =>[orig_patent_app_number] => 09209080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4410455 [patent_doc_number] => 06239265 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Oligonucleotides having chiral phosphorus linkages' [patent_app_type] => 1 [patent_app_number] => 9/208533 [patent_app_country] => US [patent_app_date] => 1998-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12194 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239265.pdf [firstpage_image] =>[orig_patent_app_number] => 208533 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406743 [patent_doc_number] => 06232294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Neuro-function regulatory agent' [patent_app_type] => 1 [patent_app_number] => 9/206692 [patent_app_country] => US [patent_app_date] => 1998-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4674 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 191 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232294.pdf [firstpage_image] =>[orig_patent_app_number] => 206692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4408688 [patent_doc_number] => 06239115 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-29 [patent_title] => 'Dry flowable polyoxin compositions' [patent_app_type] => 1 [patent_app_number] => 9/192331 [patent_app_country] => US [patent_app_date] => 1998-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6075 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/239/06239115.pdf [firstpage_image] =>[orig_patent_app_number] => 192331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4085543 [patent_doc_number] => 06162797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Derivatives of K5 polysaccharide having high anticoagulant activity' [patent_app_type] => 1 [patent_app_number] => 9/180406 [patent_app_country] => US [patent_app_date] => 1998-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 3214 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162797.pdf [firstpage_image] =>[orig_patent_app_number] => 180406 [rel_patent_id] =>[rel_patent_doc_number] =>)